Roquette (La Madeleine, France) is launching two new plant-based textured proteins in order to address consumer demand for sensory, diversity, and sustainable nutritional improvements.
Tea consumers are becoming more savvy and adventurous, putting a premium on quality, and seeking better-for-you, functional options to supplement their health.
The Supreme Court’s denial means that the decision of the ITC to not investigate Amarin’s complaints remains upheld by the U.S. Circuit Court of Appeals for the Circuit Court, and no further appeals are possible.
The formulations will have a special focus on fighting cellular oxidative stress, support of intracellular health such as of the mitochondria, and telomerase research.
A recently published study found that a standardized saffron extract, Affron from Pharmactive Biotech Products, may be a beneficial adjunct to antidepressants.
Roquette Ventures invests in Advanced Protein Technologies, to accelerate development of human milk oligosaccharides
Roquette Ventures and Advanced Protein Technologies, a bio venture company developing human milk oligosaccharides (HMOs), have signed an agreement to work together on the development of new human breast milk components.
A recently published animal study found that supplementation with a patented pterostilbene, Silbinol from Sabinsa Corp., had cardioprotective properties in subjects.
The Global Organization for EPA and DHA Omega-3s (GOED) has published the 2017-2018 edition of its annual Global EPA and DHA Omega-3 Ingredient Market Report.
This continued partnership will now expand distribution into Australia, where ChromaDex recently received approval for its nicotinamide riboside chloride as an ingredient in listed Complementary Medicines from the Australian Therapeutic Goods Administration.
As part of the long-term partnership, Indena will continue to manufacture ingredients for Givaudan, provide innovation capabilities, and other supporting services.